,足球博彩app(www.hg108.vip)是一个开放皇冠即时比分、代理最新登录线路、会员最新登录线路、皇冠代理APP下载、皇冠会员APP下载、皇冠线路APP下载、皇冠电脑版下载、皇冠手机版下载的皇冠新现金网平台。足球博彩app上登录线路最新、新2皇冠网址更新最快,足球博彩app开放皇冠会员注册、皇冠代理开户等业务。
KUALA LUMPUR: Ta Win Holdings Bhd has proposed to dispose of its entire 32.5% stake or 3.897 million ordinary shares in Royce Pharma Manufacturing Sdn Bhd for RM20.85mil.In a Bursa filing, the copper wires and rods manufacturer said its wholly-owned subsidiary Ta Win Copper Biohealth Sdn Bhd has entered into a share sale agreement with Poly Laboratories Sdn Bhd and Jelita Serbaneka Sdn Bhd for the proposed disposal.Upon completion of the proposed disposal, Ta Win continues to account for investment in Royce Pharma as an associate company via its 1.8 million preference shares.“The proposed disposal represents an opportunity for Ta Win to dispose of its healthcare and pharmaceutical business segment for a pricing term which is no less than favourable (i.e. the disposal consideration is no less than its original cost of investment) in the current challenging operating environment,” it said.It added that the proposed disposal is deemed as a strategic reorganisation plan to better realign the vision of Ta Win to become a prominent integrated one-stop copper-solutions provider in the South East Asian region.
评论列表 (0条)